ALMS vs VRTX: Which Stock is Better?
Side-by-side comparison of Alumis Inc and Vertex Pharmaceuticals Inc in 2026
ALMS
Alumis Inc
$26.34
VRTX
Vertex Pharmaceuticals Inc
$492.38
Key Metrics Comparison
| Metric | ALMS | VRTX | Winner |
|---|---|---|---|
| Market Cap | $3.50B | $126.79B | VRTX |
| P/E Ratio | N/A | 32.58 | VRTX |
| EPS (TTM) | $N/A | $15.32 | VRTX |
| Revenue Growth | 0.0% | 0.1% | VRTX |
| Gross Margin | 100.0% | 53.7% | ALMS |
Analyze ALMS
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ALMS or VRTX a better investment?
Comparing ALMS and VRTX: Alumis Inc has a market cap of $3.50B while Vertex Pharmaceuticals Inc has $126.79B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ALMS and VRTX?
ALMS (Alumis Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ALMS or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ALMS or VRTX?
VRTX has higher revenue growth at 0.1% vs 0.0% for ALMS.
Which company is more profitable: ALMS or VRTX?
Alumis Inc (ALMS) has higher gross margins at 100.0% compared to 53.7% for VRTX.
Which is the larger company: ALMS or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $126.79B compared to $3.50B for ALMS.
Should I buy ALMS or VRTX in 2026?
Both ALMS and VRTX have investment merit. ALMS trades at $26.34 while VRTX trades at $492.38. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ALMS and VRTX stock?
Key differences: Market Cap ($3.50B vs $126.79B), P/E Ratio (N/A vs 32.6x), Revenue Growth (0.0% vs 0.1%), Gross Margin (100.0% vs 53.7%).